Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Cash Dividends Charged to Retained Earnings This Quarter
QFR120385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
20,579.00
Year-over-Year Change
24.96%
Date Range
10/1/2000 - 4/1/2025
Summary
This trend tracks cash dividends charged to retained earnings specifically for U.S. pharmaceutical and medicine corporations on a quarterly basis. It provides critical insight into corporate financial health and shareholder distribution strategies in a key healthcare industry sector.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The metric represents the amount of accumulated corporate profits that pharmaceutical companies distribute to shareholders as dividend payments. Economists use this indicator to assess corporate financial performance, investment strategies, and overall sector economic vitality.
Methodology
Data is collected through comprehensive quarterly financial reporting by publicly traded pharmaceutical corporations, compiled and standardized by federal economic research institutions.
Historical Context
This trend helps policymakers, investors, and analysts understand corporate financial dynamics, investment patterns, and economic performance in the pharmaceutical healthcare sector.
Key Facts
- Represents quarterly cash dividend distributions in pharmaceutical sector
- Indicates corporate financial strategy and shareholder value
- Provides insights into healthcare industry economic performance
FAQs
Q: What does this economic indicator measure?
A: It tracks cash dividends charged to retained earnings for U.S. pharmaceutical and medicine corporations on a quarterly basis.
Q: Why are pharmaceutical dividend trends important?
A: These trends reveal corporate financial health, investment strategies, and potential future growth in the healthcare sector.
Q: How is this data collected?
A: Data is gathered through mandatory quarterly financial reports from publicly traded pharmaceutical companies.
Q: How do investors use this information?
A: Investors analyze these trends to assess corporate performance, potential returns, and sector-wide financial dynamics.
Q: How frequently is this data updated?
A: The data is typically updated on a quarterly basis, reflecting the most recent financial reporting period.
Related Trends
Quarterly Financial Report: U.S. Corporations: All Other Retail Trade: Property, Plant, and Equipment
QFR216OTRUSNO
Quarterly Financial Report: U.S. Corporations: Computer and Electronic Products: Total Current Assets
QFRTCACOMUSNO
Contributions to the Chicago Fed Relative Midwest Economy Index: Michigan Contribution: Manufacturing Sector
RMANUMIM683SFRBCHI
Quarterly Financial Report: U.S. Corporations: Nonmetallic Mineral Products: Cash and Demand Deposits in the U.S.
QFR201327USNO
Quarterly Financial Report: U.S. Corporations: Aerospace Products and Parts: Total Liabilities
QFRTL386USNO
Chicago Fed National Financial Conditions Index Nonfinancial Leveral Subindex
NFCINONFINLEVERAGE
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Cash Dividends Charged to Retained Earnings This Quarter [QFR120385USNO], retrieved from FRED.
Last Checked: 8/1/2025